NewsClean Science & Technology Grants 5,000 Employee Stock Options at Rs.500 Exercise Price Under ESOP Scheme 2021Clean Science & Technology Grants 5,000 Employee Stock Options at Rs.500 Exercise Price Under ESOP Scheme 2021
Clean Science & Technology's Nomination and Remuneration Committee approved the grant of 5,000 stock options to eligible employees on May 14, 2026, under CSTL ESOS 2021. Each option is exercisable at Rs.500 per option and is convertible into one equity share with a face value of Re. 1/- each. The options vest over four years — 20% each in 2027, 2028, and 2029, and 40% in 2030 — with a one-year exercise window from each vesting date. The grant is compliant with SEBI (Share Based Employee Benefit and Sweat Equity) Regulations, 2021.
*this image is generated using AI for illustrative purposes only.
Clean Science & Technology 's Nomination and Remuneration Committee (NRC) approved the grant of 5,000 Employee Stock Options (ESOPs) to eligible employees on Thursday, May 14, 2026. The grant was made under the Clean Science and Technology Limited Employee Stock Option Scheme 2021 (CSTL ESOS 2021), in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the SEBI (Share Based Employee Benefit and Sweat Equity) Regulations, 2021. The company disclosed this development to both BSE Limited and the National Stock Exchange of India Limited.
Key Details of the ESOP Grant
The following table summarises the core parameters of the stock option grant approved by the NRC:
| Parameter: | Details |
|---|---|
| Number of Options Granted: | 5,000 (Five Thousand) Stock Options |
| Scheme Name: | Clean Science and Technology Limited Employee Stock Option Scheme 2021 |
| Equity Shares Covered: | 5,000 (Five Thousand) Equity Shares |
| Face Value per Share: | Re. 1/- each |
| Exercise Price: | Rs.500/- (Rupees Five Hundred Only) per option |
| Conversion Ratio: | Each Stock Option is convertible into One (1) Equity Share |
| SEBI Compliance: | Yes — SEBI (Share Based Employee Benefit and Sweat Equity) Regulations, 2021 |
Vesting Schedule
The 5,000 stock options are subject to a four-year vesting schedule. The vesting is structured progressively, with a larger portion vesting in the final year. The detailed vesting schedule is as follows:
| Date of Vesting: | Vesting Percentage |
|---|---|
| 14.05.2027 | 20% of options granted |
| 14.05.2028 | 20% of options granted |
| 14.05.2029 | 20% of options granted |
| 14.05.2030 | 40% of options granted |
The exercise period for each tranche is 1 (one) year from the respective date of vesting. This means eligible employees must exercise their vested options within one year of each vesting date.
Scheme Administration and Eligibility
The CSTL ESOS 2021 is administered by the Nomination and Remuneration Committee. The grant of stock options is based on the eligibility criteria as specified under the CSTL ESOS 2021 scheme. The company has confirmed that no options have been exercised, lapsed, or cancelled in connection with this grant, and there are no variations to the terms of the options at this stage.
The intimation was signed by Ruchita Vij, Company Secretary and Compliance Officer of Clean Science & Technology, and submitted to the stock exchanges on May 14, 2026.
Historical Stock Returns for Clean Science & Technology
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.47% | -16.27% | -0.65% | -18.81% | -41.42% | -52.83% |
How does the Rs. 500 exercise price compare to Clean Science & Technology's current market price, and what does this premium or discount signal about management's confidence in the company's long-term valuation?
Given the back-weighted vesting schedule with 40% vesting in 2030, which specific employee roles or leadership positions are likely being targeted to drive retention through this ESOP grant?
How might Clean Science & Technology's total ESOP pool utilization under the CSTL ESOS 2021 scheme impact future earnings per share dilution as more tranches vest through 2030?
16
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
